Clinical trial
Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine…
NCT00242983 · National Hospital Organization Kinki-chuo Chest Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00242983 |
|---|---|
| Title | Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer |
| Official title | Assessment of Quality of Life (QOL) in Patients Registered With "Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)" |
| Lead sponsor | National Hospital Organization Kinki-chuo Chest Medical Center, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Lung Cancer |
| Intervention type | Procedure |
| Interventions | quality-of-life assessment |
| Start date | Apr 1, 2004 |
| First posted | Oct 21, 2005 |
| Last update posted | Dec 18, 2013 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: